Lv5
820 积分 2021-03-16 加入
Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis
2个月前
已关闭
Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system
2个月前
已关闭
Safety and Efficacy of Osimertinib in Patients With Non–Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis
2个月前
已完结
Osimertinib-Induced Lichenoid Drug Eruption: A Case Report
2个月前
已关闭
Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
2个月前
已完结
Comparative Safety of Ibrutinib Versus Zanubrutinib in Patients With Chronic Lymphocytic Leukemia: A Prospective Cohort Study
2个月前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
2个月前
已完结
Real world outcomes with Ibrutinib monotherapy in Chronic Lymphocytic Leukemia: a single center experience
2个月前
已完结
Real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies
2个月前
已完结
A Novel Oncogenic and Drug-Sensitive KIF5B-NTRK1 Fusion in Lung Adenocarcinoma
3个月前
已完结
皖公网安备34019202002308
